GlassScriptPhysician profile
Allen Ahdoot
NPI 1053364323
$2,196.71
in general payments reported to CMS, 2019-2025
16 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $191 · 2021: $390 · 2022: $361 · 2023: $362 · 2024: $447 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $965.65 | 2019-2025 | Xifaxan, Plenvu |
| Abbvie INC. | $248.46 | 2020-2024 | |
| Madrigal Pharmaceuticals | $145.92 | 2024 | Rezdiffra |
| Boston Scientific Corporation | $138.40 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $135.00 | 2023 | Austedo |
| Phathom Pharmaceuticals, INC. | $125.00 | 2025 | Voquezna |
| Braintree Laboratories, INC. | $105.65 | 2019-2023 | Sutab |
| Janssen Biotech, INC. | $79.63 | 2024 | Tremfya |
| Allergan, INC. | $58.59 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.21 | 2021 | |
| Abbott Laboratories | $42.92 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.82 | 2019 | |
| Celgene Corporation | $24.46 | 2024 | Zeposia |
| Ferring Pharmaceuticals INC. | $22.66 | 2019 | |
| Ironwood Pharmaceuticals, INC | $21.36 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $14.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Ahdoot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.